
RB · Tampa Bay Buccaneers
Cast your verdict:
A low-upside camp body signing immediately undermined by a major PEDs suspension. Headlines overwhelmingly focus on the suspension, casting serious doubt on Williams' NFL viability. The drug policy violation is a critical red flag that wipes out any developmental upside. Fans note the irony of a kick return highlight quickly overshadowed by league discipline. Williams faces an uphill battle just to make a roster, let alone contribute meaningfully.
This signing grades out as a great value signing for the Tampa Bay Buccaneers — the team is getting significantly more on-field production than what they're paying for. Josh's on-field performance ranks in the middle of the pack among NFL RBs, grading him as a serviceable starter at the position. His $4.0M average annual value ranks as bargain money for the RB market. The value equation works strongly in the team's favor — they're getting serviceable starter production at bargain cost, which is the kind of financial efficiency that builds roster depth. Josh is squarely in his prime, which adds to the deal's upside — the team should get multiple productive seasons out of this contract. The 2-year, $8.0M deal ($3.2M guaranteed, 41%) keeps the commitment short, giving the team financial flexibility to move on if performance drops.
Cast your verdict:
No fan votes yet. Be the first!
Auto-moderated fan forum with 5-minute speaker turns
Loading discussion...